Introduction {#sec1}
============

Bacteria of the genus *Brucella* are the etiological agents of brucellosis, the most widespread zoonotic disease worldwide, resulting in more than 500 000 new reported human cases per year.([@ref1]) Animal brucellosis is a disease affecting wild and domestic animals, causing abortion and sterility and producing huge economic losses.([@ref2]) Several of the nine *Brucella* species can infect humans, causing a chronic, debilitating disease with severe and sometimes fatal outcomes. As a result, these bacteria represent a significant public health concern in endemic countries (predominantly in the Mediterranean region and areas of Asia, Africa and Latin America).^[@ref1],[@ref3]^ Because of their potential use as weapons, *B. melitensis*, *B. suis* and *B. abortus* strains have been classified as select agents by the Center for Disease Control and Prevention in the U.S.A.([@ref4])

*Brucella* strains are Gram-negative intracellular pathogens belonging to the α-2 proteobacteria group. The virulence of these bacteria is based on their capacity to infect professional and nonprofessional phagocytes.^[@ref5]−[@ref8]^ This remarkable adaptation to the intracellular environment and their ability to modulate the host innate immune response([@ref9]) allows the *Brucellae* to establish and maintain chronic infections. During host cell infection, *Brucella* containing vacuoles (BCVs) traffic along the endocytic pathway and fuse transiently with both late endosomes and lysosomes, and such interactions are required for further maturation of BCVs into an ER-derived replication-permissive organelle.([@ref10]) The virulence strategies of these bacteria seem to be based on poor stimulatory activity and toxicity for host cells,([@ref9]) resistance to intracellular killing,([@ref11]) adaptation to intracellular stresses^[@ref12],[@ref13]^ and creation of the replication-permissive compartment in professional and nonprofessional phagocytes.^[@ref8],[@ref14]^

During infection, *Brucella* spp. are confronted with very diverse environments and host defense mechanisms.^[@ref12],[@ref15]−[@ref17]^ Thus, completion of a successful infection cycle is crucially dependent on fine-tuning gene expression in response to environmental stimuli.([@ref18]) Among the systems that allow such regulations, quorum sensing (QS) is of particular interest because of its documented involvement in the virulence of *Brucella*([@ref19]) and other pathogens.^[@ref20],[@ref21]^ QS is a communication system used by a large number of bacteria to synchronize gene expression within a population. This system involves the synthesis, release and subsequent detection of small diffusible molecules called autoinducers (commonly *N*-acyl-homoserine lactones or AHLs in Gram-negatives bacteria). When AHL concentrations reach a threshold level, they bind to LuxR-type transcriptional regulators and modify their activity (for review see ref ([@ref22])). Since QS was first discovered in *V. fischeri* in the late 1970s,([@ref23]) the conceptual role of this communication system in prokaryotic biology has evolved considerably. QS was first described as a system allowing bacteria to sense population density.([@ref24]) However, the autoinducer concentrations can be affected by numerous parameters like diffusion, spatial distribution, and degradation.^[@ref25],[@ref26]^ These latter factors are particularly relevant given the intravacuolar localization of *Brucella* spp. in host cells.

Genes encoding two LuxR-type regulators have been identified in the *B. melitensis* 16 M genome,([@ref27]) the previously described VjbR regulator^[@ref19],[@ref28]^ and BabR,([@ref29]) also known as BlxR.([@ref30]) While the virulence of a Δ*vjbR* strain is highly attenuated in all experimental model tested, BabR seems *to* play a minor, if any role, in *B. melitensis* 16 M virulence.([@ref31]) Despite the lack of a gene encoding a classical AHL synthase in the genome of *B. melitensis*, we have previously identified low amounts of C~12~−HSL in culture supernatants from these strains.([@ref32]) This autoinducer down-regulates the expression of flagellar genes,([@ref19]) and the expression of the *virB* operon encoding a Type four secretion system (T4SS),^[@ref32],[@ref33]^ two virulence factors involved in the establishment of chronic infection([@ref34]) and the control of *Brucella* containing vacuole (BCV) maturation, respectively.([@ref35]) Experimental evidence suggests that VjbR mediates the effect of C~12~−HSL on *virB* transcription([@ref28]) by binding to a 18 bp palindromic motif in the *virB* promoter.([@ref36]) Moreover it was recently demonstrated that VjbR is involved in the regulation of exopolysaccharide (EPS) synthesis and/or export and the production of several outer membrane proteins (OMPs), some of which are involved in virulence, suggesting that this regulator plays a crucial role in the regulation of the surface properties of *B. melitensis* 16 M.([@ref28])

The work described in this paper is the first attempt to identify the QS regulon of an intracellular pathogen. To accomplish this, we characterized Δ*babR* and Δ*vjbR* mutants by 2D-DIGE and microarray analysis on the same samples. We identified 101 QS targets using the proteomic approach and 338 QS target genes by transcriptome analysis. To focus on the most confident targets, we focus only on those that were identified by both proteomic and microarray analysis and those from the microarray analysis that were confirmed by qRT-PCR, chromatin immunoprecipitation (chIP) or other biological validation experiments. This combinatorial screen allowed us to select 149 VjbR and BabR target genes representing 4.7% of the *B. melitensis* 16 M genome. Interestingly many of these targets were regulated by both VjbR and BabR, suggesting a cross-talk between these two LuxR type regulators. Our analysis revealed that the QS system of this intracellular bacterium is a global regulatory system because VjbR and BabR control (directly or not) genes and proteins involved in stress response, metabolic adaptation and virulence. In the light of these results, we therefore propose that the *B. melitensis* QS system may play a role in fine-tuning the spatiotemporal adaptation of the bacteria to their intracellular niche.

Experimental section {#sec2}
====================

Bacterial Strains and Culture Conditions {#sec2.1}
----------------------------------------

*Brucella melitensis* strains were grown with shaking at 37 °C in 2YT medium (10% yeast extract, 10 g L^−1^ tryptone, 5 g L^−1^ NaCl) containing the appropriate antibiotics, from an initial optical density at 600 nm (OD~600~) of 0.05. For transcriptomic and proteomic analyses, 100 mL of 2YT without antibiotic were inoculated with wild-type strain, Δ*vjbR* or Δ*babR* mutants to an OD~600~ of 0.05. Cultures were grown in triplicate, and incubated at 37 °C with shaking to an OD~600~ of 0.75. Ten milliliters of culture was used for protein preparation, and the rest was used for RNA extraction.

Nalidixic acid (Nal) and gentamycin (Gnt) were used at 25 μg mL^−1^ and 50 μg mL^−1^ respectively. Synthetic *N*-dodecanoyl-[dl]{.smallcaps}-homoserine lactone (C~12~−HSL; Fluka) was prepared in acetonitrile (ACN) and added to bacterial growth media at 5 μM final concentration. The same volume of ACN was used as a negative control.

Mutant Construction {#sec2.2}
-------------------

The Δ*babR* and Δ*vjbR* mutant strains were constructed by gene replacement employing a kanamycine resistance gene and previously described procedures.^[@ref19],[@ref31]^

For ChIP experiments, the plasmid pSB502 harboring a C-terminal fusion between the flag tag and the *vjbR*~*HTH*~ region coding for the HTH region of VjbR (amino acids 181 to 260) was designed as following. First, we constructed the Gateway destination vector pSB500 allowing C-terminal fusions of an ORF with the flag epitope under P*lac* control. The Gw-Flag cassette was excised from the pGEMT-Gw-FLAG Cter (from Geraldine Laloux) by an *Apa*I/*Sac*I restriction. The resulting fragment was purified and ligated in the pBBR1MCS-5([@ref37]) plasmid restricted by the same enzymes to obtain the destination vector pSB500 (containing a Gnt resistance cassette). The entry clone pSB102 containing *vjbR*~*HTH*~([@ref28]) was used together with the destination vector pSB500 during Gateway LR reaction as described by Dricot and co-workers.([@ref38]) The resulting vector pSB502 and the pBBRmcs-5 plasmid (negative control) were introduced in *Brucella melitensis* Δ*vjbR* strain by mating.

Matings were performed by mixing 200 μL of *E. coli* S17−1 donor cells liquid culture (overnight culture) and 1 mL of the *B. melitensis* Nal^R^ recipient strain (overnight culture). Cells were centrifuged 2 min at 7000 rpm and washed two times with 2YT. The pellets were resuspended in 10 μL of 2YT and spotted on a 2YT plate for 4 h. Bacteria were then transferred onto a 2YT plate containing Gnt and Nal. After 3 days of incubation at 37 °C, the exconjugates were replicated on a 2YT plate containing Nal and Gnt.

Microarray Experiments {#sec2.3}
----------------------

### RNA Preparation {#sec2.3.1}

Total RNA was extracted from *B. melitensis* 16 M and the isogenic Δ*vjbR* and Δ*babR* mutants (all cultured in triplicate) as follows: 45 mL of culture (OD~600~ of 0.75) were centrifuged at 3500 rpm for 15 min. Bacterial pellets were resuspended in 100 μL SDS 10% and 20 μL proteinase K (20 mg mL^−1^) and incubated at 37 °C with shaking for 1 h. Five milliliters of TRIzol Reagent (Invitrogen) were added and suspensions were vigorously shacken. After 10 min of incubation at 65 °C, 1 mL chloroform was added to the suspensions and the mixtures were shacken and incubated at room temperature for 5−10 min. Samples were then centrifuged at 14.000 rpm for 15 min at 4 °C. Then, 2.5 mL 2-propanol were added to the aqueous phases and samples were stored overnight at −20 °C. After centrifugation for 30 min at 14.000 rpm at 4 °C, pellets were washed with 75% (RNase free) ethanol. Supernatants were discarded and pellets were dried 15 min at room temperature. Total RNA samples were resuspended in 100 μL RNase free water, incubated 10 min at 55 °C and stored at −80 °C. The integrity of the RNA and the absence of DNA were checked by gel electrophoresis. RNA quantity was measured using a NanoDrop spectrophotometer (ND-1000, Thermo Fisher Scientific).

### Microarray Analysis {#sec2.3.2}

Microarray design and analysis were made by NimbleGen Systems, Inc. from catalogue design for *B. melitensis* 16 M chromosomes I (NC_003317) and II (NC_003318) with 20 probes per gene (10 perfect matches and 10 mismatches). Each probe (24 mer) was replicated three times on a chip (design includes random GC probes). Triplicate RNA samples of each strain were mixed and one chip was analyzed per strain. The data discussed in this publication have been deposited in NCBI's Gene Expression Omnibus and are accessible for reviewers through GEO Series accession number GSE8844 (<http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?token=jzmhfuoccmeugfi&acc=GSE8844>).

All of the analysis was performed using the statistical program in the *stats* package.([@ref39]) Data obtained from the microarray analysis were preprocessed using the RMA algorithm,([@ref40]) as provided by NimbleGen Systems, Inc. Two pair wise comparisons were performed (Δ*vjbr* vs wt) and (Δ*babr* vs wt). For each comparison, the fold change was computed as the ratio of intensity averages (mutant/wt). A Student *t* test was used for statistical analysis of overexpression and under-expression. Genes presenting both a fold change greater than 1.3 (or below 0.7) and statistical significance at the alpha level 0.005 were defined as being over- or under-expressed between the two strains being compared.

Two-Dimensional Difference in Gel Electrophoresis (2D-DIGE) {#sec2.4}
-----------------------------------------------------------

### Samples Preparation and Electrophoresis {#sec2.4.1}

Proteins were extracted from 10 mL of *B. melitensis* 16 M and Δ*vjbR* and Δ*babR* cultures (OD~600~ 0.75) in triplicate. Cultures were centrifuged at 3500 rpm for 10 min. Bacterial pellets were washed three times with 20 mL PBS before resuspension in 2 mL chloroform. The mixtures were incubated at room temperature for 1 h and then centrifuged at 3500 rpm for 10 min at 4 °C. Pellets were resuspended in PBS to obtain an OD~600~ of 100 and the cell suspensions subjected to three freeze/thaw cycles. Protein concentration for the cell lysates were determined using the BCA Protein Assay (Pierce) and protein concentrations were adjusted to 5−10 μg μL^−1^. Samples were divided into 100 μg aliquots and one volume of 10% trichloroacetic acid (TCA) was added. The mixtures incubated for 5 min on ice and centrifuged at 14 000 rpm for 3 min at 4 °C. Pellets were resuspended in one volume of 5% TCA and the mixes were incubated 5 min on ice. Samples were centrifuged at 14 000 rpm for 3 min at 4 °C and pellets were washed with ice cold acetone. After centrifugation an additional centrifugation step, pellets were resuspended in a mix of 40 μL Buffer 1 (40 μM Tris HCl pH 8.5, 0.3% SDS) and 4 μL Buffer 2 (0.4 M Tris HCl pH 8.5, 1 mg mL^−1^ DNaseI, 0.25 mg mL^−1^ RNase A; 50 mM MgCl~2~).

We used the 2D-DIGE method to compare total protein extracts from wt and Δ*vjbR* strains and from wt and Δ*babR* strains. For each comparison, two types of gels (pH 4−7 and pH 7−11 NL) were run in triplicate. Proteins were labeled with CyDye DIGE Fluor, minimal dyes (GE Healthcare) according to the manufacturer, which allows the detection of two prelabeled protein samples and an internal standard on the same 2-D electrophoresis gel. Two samples of 25 μg (wt and Δ*vjbR* or wt and Δ*babR*) were labeled with Cy3 and Cy5, respectively, and analyzed on the same gel together with an internal standard labeled with Cy2 (25 μg). The internal standard was a pool that included an equal amount of proteins of all samples run on triplicate gels. Labeled proteins were first separated by isoelectric focusing in immobilized pH gradient (IPG) gels, linear pH 4−7 gradient or nonlinear pH 7−11 gradient, using IPGphor (GE Healthcare). IPG pH 4−7 gels were run for 3 h at 300 V, 6 h at 1000 V, 3 h at 8000 V and 50 000 Vh at 8000 V and nonlinear IPG pH 7−11 gels were run for 4 h at 500 V, 7 h at 1000 V, 3 h at 8000 V and 60 000 Vh at 8000 V. First-dimension gels were laid on the top of 10% polyacrylamide gels and run using the Ettan Dalt II System (GE Healthcare) at constant 1.5W per gel for 18 h overnight at 15 °C. Gels were scanned with the Typhoon 9600 laser scanner (GE Healthcare) and images were analyzed with the DeCyder Differential Analysis Software (GE Healthcare).

The differential in-gel analysis mode of the DeCyder software was used to merge the Cy2, Cy3, and Cy5 images for each gel, to detect spot limits for the calculation of normalized spot volumes/protein abundances and to determine abundance differences between samples run on the same gel. The biological variation analysis mode of DeCyder was then used to match all pairwise image comparisons from difference in-gel analyses for a comparative cross-gel statistical analysis. Comparison of normalized Cy3 and Cy5 spot volumes with the corresponding Cy2 standard spot volumes within each gel gave a standardized abundance. This value was compared across all gels for each matched spot and a statistical analysis was performed. The Biological Variation Analysis (BVA) provides the average ratios between *B. melitensis* 16 M and mutated strain, with a threshold at ±1.3 and a *t* test confidence of ≤0.05, generating a list of spots of interest. All selected spots were picked, digested and identified using LC−MS/MS.

### Mass Spectrometry and Protein Identification {#sec2.4.2}

To identify selected spots, preparative gels including 300 μg of proteins (from *B. melitensis* 16 M, Δ*vjbR* and Δ*babR* triplicate samples) were performed following the protocol described above except that they were post stained with ruthenium(II) tris(bathophenanthroline disulfonate) overnight (7 μL of ruthenium/1 L of 20% ethanol) after 6 h of fixation in 30% ethanol, 10% acetic acid and 3 × 30 min in 20% ethanol at 20 °C.([@ref41])

Protein spots were excised from preparative gels by using the Ettan Spot Picker (GE Healthcare) and in-gel tryptic digestion performed as previously described.([@ref42]) The gel pieces were twice washed with distilled water and then treated with 100% acetonitrile. The proteolytic digestion was performed by the addition of 3 μL of modified trypsin (Promega) suspended in 50 mM NH~4~HCO~3~ cold buffer. Proteolysis was performed overnight at 37 °C. The supernatant was collected and combined with the eluate of a subsequent elution step with 5% formic acid.

### MALDI-TOF Identification {#sec2.4.3}

Digested peptides digest were desalted using C18 Geloader pipet Tips (Proxeon Biosystems) and directly eluted on the target with a mix (1:1 v/v) of α-cyano-4-hydroxyciannamic acid (in 7:3 v/v acetonitrile/0.1% formic acid) and 2,5-dihydroxybenzoic acid (in 7:3 v/v acetonitrile/0.1% trifluoracetic acid). Peptide mass fingerprints were obtained using a MALDI-MX mass spectrometer (Waters, Mildorf, U.S.A.) piloted with MassLynx 4.0 software (Waters). ProteinLynx Global Server 2.2.5 (Waters) was used as the peaklist generating software. MALDI calibration was done with ADH digest and two lockmass calibrations were used. First, an external lockmass with ADH digest (*m*/*z*: 1618.84 Da) and finally we applied an internal lockmass based on the trypsin autodigestion peak at 2211.1046 Da. The background subtract threshold was fixed at 15% (polynomial 5, we combined all spectra). An in house Mascot 2.2 server was used as database search engine, PMF search was performed on the Proteobacteria subset of the National Center for Biotechnology Information nonredundant database (NCBInr; 1 391 518 sequences in October 2008). Parameters for peptide matching were a peptide tolerance of 100 ppm, a maximum of one missed cleavage, carbamidomethylation was allowed as a fixed modification and oxidation of methionine was allowed as a variable modification. For all protein identifications, a minimal individual score of 73 and expected value below 1 were used for the identification criteria. All MS/MS spectra can be found in the [Supporting Information](#si1){ref-type="notes"}.

### Q-TOF Identification {#sec2.4.4}

The digests were separated by reverse phase liquid chromatography using a 75 μm × 150 mm reverse phase NanoEase column (Waters) in a CapLC (Waters) liquid chromatography system. Q-TOF2 and CapLC systems were piloted by MassLynx 4.0 (Waters). Peak lists were created using Mascot Distiller 2.2 (Matrix Science). Enzyme specificity was set to trypsin and the maximum number of missed cleavages per peptide was set at 1. Carbamidomethylation was allowed as a fixed modification and oxidation of methionine was allowed as a variable modification. Mass tolerance for the monoisotopic precursor peptide window was set to 100 ppm and MS/MS tolerance window to ±0.3 Da. We also specified ESI-Q-TOF as the instrument. The peak lists were searched against the Proteobacteria subset of the National Center for Biotechnology Information nonredundant database (NCBInr; 1 391 518 sequences in October 2008). For all protein identifications, a minimal individual ions score of 45 (identity score) and expected value below 1 were used for the initial identification criteria. In the case of redundant protein identifications, the protein identification with the highest score was selected. Moreover, the correlation between theoretical pI and molecular mass of the protein with the position of the corresponding spot in the 2D gel was also taken into account. All MS/MS spectra can be found in the [Supporting Information](#si1){ref-type="notes"}.

Quantitative Real-Time RT-PCR {#sec2.5}
-----------------------------

Total RNA samples were prepared as described above on *B. melitensis* 16 M wild-type strain grown in 2YT with 5 μM final concentration C~12~−HSL or ACN at 37 °C with shaking to an OD~600~ of 0.75. DNA was removed from the samples using the DNA-free kit (Ambion) and reverse-transcription performed with SuperScript II Reverse Transcriptase (Invitrogen). cDNA samples were used as template in real-time PCR reactions. Primers were designed with the PrimerExpress 2.0 (Applied Biosystems; sequences are listed in Table 3, [Supporting Information](#si1){ref-type="notes"}), PCR products ranged from 80 to 100 bp. Real-time PCR reactions were performed with SYBR Green Mix (Applied Biosystems) in 96-well Optical Reaction plates (Applied Biosystems). Ratios were calculated using the ΔΔCT method for each primer in an Applied Biosystems Step One Plus real-time PCR instrument. Results for each target mRNA was normalized to BMEI0861 mRNA and averaged.

Chromatin Immunoprecipitation Assay {#sec2.6}
-----------------------------------

Δ*vjbR* pSB502 (encoding *vjbR*~*HTH*~ C-terminal flag fusion) and Δ*vjbR* pBBR1MCS-5 (negative control) strains were grown in 2YT at 37 °C to an OD~600~ of 0.75. ChIP experiments were performed essentially as described([@ref43]) using antiflag m2 monoclonal antibodies (Sigma). Briefly, after bacterial growth, formaldehyde (1%) was added to 10 mL of triplicate cultures and the cultures placed at room temperature for 10 min before quenching the reaction with glycine (125 mM) for 5 min. Bacteria were collected and washed with cold phosphate-buffered saline twice. The cells were lysed in 0.9 mL of lysis solution (10 mM Tris pH 8.0, 50 mM NaCl, 10 mM EDTA, 20% sucrose, 20 mg mL^−1^ lysozyme) and 0.9 mL of 2× RIPA solution (100 mM Tris pH 8.0, 300 mM NaCl, 2% Nonidet P-40, 1% sodium deoxycholate, 0.2% SDS). The cell extracts were sonicated to fragment DNA to an average size of 500 bp and centrifuged 30 min at 13 000 rpm 4 °C, supernatants were stored at −80 °C. Fifteen μL of the extract was removed for total DNA preparation. For immunoprecipitation of VjbR cross-linked DNA, a portion of the extracts (500 μL) was first cleared with 80 μL of Sepharose-Protein G beads (Sigma) for 1 h at 4 °C and then incubated with 4 μL of monoclonal antiflag m2 antibodies (Sigma) for 4 h at 4 °C. The beads were washed twice with 1× RIPA solution, then twice with LiCl/detergent solution (10 mM Tris pH 8.0, 250 mM LiCl, 1 mM EDTA, 0.5% Nonidet P-40, 0.5% sodium deoxycholate), and finally with TE buffer. The immunoprecipitated material was eluted with 130 μL of elution buffer (25 mM Tris pH 8.0, 5 mM EDTA, 0.5% SDS) for 20 min at 65 °C. Cross-linking of immunoprecipitated and total DNA was reversed by incubation at 65 °C overnight. After Pronase treatment, the immunoprecipitated and total DNA were purified using the PCRapace Kit (Invitek GmbH, Germany) according to the manufacturer.

Analysis of the immunoprecipitated DNA was performed using quantitative PCR with input and immunoprecipitated DNA samples as templates. All promoter-specific primers were designed with Primer Express 1.0 (Applied Biosystems, see supplementary Figure 3) for amplicon sizes and primer localization and sequences). PCR products ranged from 80 to 100 bp. Real-time PCR reactions were performed in 25 μL SYBR Green Mix (Applied Biosystems) in 96-well Optical Reaction plates (Applied Biosystems). Relative quantification using a standard curve method was performed for each primer in an Applied Biosystems 7900HT real-time PCR instrument (absolute quantification method). Input DNA values were used to normalize ChIP, which are presented as a percentage of precipitated DNA (IP)/total DNA (IN).

Assessment of *B. melitensis* Stress Responses {#sec2.7}
----------------------------------------------

### Alkaline and Acid Resistance {#sec2.7.1}

*B. melitensis* 16 M and isogenic Δ*vjbR* and Δ*babR* strains were grown in 2YT up to an OD~600~ of 1.0 and diluted to an OD~600~ of 0.05 in 2YT adjusted to the required pH with HCl or NaOH. Cultures were incubated at 37 °C with shaking for 72 h, and OD~600~ were measured after 24, 48, and 72 h of incubation.

### Resistance to Bile Salts {#sec2.7.2}

In vitro resistance of *B. melitensis* 16 M and the Δ*vjbR* and Δ*babR* strains to bile salts was evaluated as follows. The wt, Δ*vjbR* and Δ*babR* strains were grown in 2YT up to an OD~600~ of 1.0 and were diluted to an OD~600~ 0.05 in 2YT or in 2YT containing 0.1% bile salts (Fluka). Cultures were then incubated at 37 °C with shaking for 18 h and serial dilutions were plated on 2YT medium for CFU counting.

Results and Discussion {#sec3}
======================

Proteomic Analysis of Brucella QS Mutants {#sec3.1}
-----------------------------------------

To define the QS regulon of *B. melitensis* 16 M, we compared both QS mutants (Δ*vjbR* and Δ*babR*) to the parental (wt) strain by proteomic analysis. Knowing that VjbR, BabR and several virulence factors are expressed during midexponential growth phase, total proteins were extracted under these conditions. 2D-DIGE was then used to compare total protein extracts from three independent midexponential phase cultures of *B. melitensis* 16 M and isogenic Δ*vjbR* and Δ*babR* mutants. For each comparison, two types of gels (pH 4−7 and pH 7−11 NL) were run. Two samples (wt/Δ*vjbR* or wt/Δ*babR*) labeled with Cy3 and Cy5 respectively, were analyzed on the same gel, together with an internal standard labeled with Cy2 (see [Material and Methods](#sec2) section). We defined a protein as being affected by the mutation of VjbR or BabR if a difference in abundance of a least 30% compared to the wt strain (Student *t* test *p* \< of 0.05) was observed for that protein in all three gels (one gel for each independent culture). Selected proteins spots corresponding to the 101 different proteins listed in Table [1](#tbl1){ref-type="table"} were picked, digested and identified using LC−MS/MS. The production of 35 of these proteins is directly or indirectly regulated by VjbR and 66 by BabR. Interestingly, numerous identified proteins are predicted to be involved in metabolic pathways such as central metabolism or amino acid metabolism, respiration, transport of amino acids, sugars and other molecules, secretion and translation.

###### Targets Identified by 2D-DIGE Analysis[a](#tbl1-fn1){ref-type="table-fn"}

  A                                                                                                                                                                                                                  
  --------------------------- ----------- --------------------------------------------------------------------------------------------------------------------------------- ------------ ------ ------- ---- ------ -----------
  Δ*babR*, pH 4−7                                                                                                                                                                                                   
  A.A metabolism              BMEI0231    NAD specific glutamate dehydrogensase                                                                                             AAL51413.1   0.37   2       1    194    Q-TOF
                              BMEI0451    2-isopropyl malate synthase                                                                                                       AAL51632.1   0.21   3       5    183    Q-TOF
                              BMEI0811    [l]{.smallcaps}-serine dehydratase                                                                                                AAL51992.1   0.66   5       10   267    Q-TOF
                              BMEI0979    Glutamine synthase                                                                                                                AAL52160.1   0.30   2       4    125    Q-TOF
                              BMEI1620    Ornithine carbamoyltransferase                                                                                                    AAL52801.1   0.64   2       4    99     Q-TOF
                              BMEI1638    Glutamate synthase                                                                                                                AAL52819.1   2.21   4       9    267    Q-TOF
                              BMEII0371   β-alanine pyruvate transaminase                                                                                                   AAL53613.1   1.78   6       16   412    Q-TOF
                              BMEII0559   Aminomethyltransferase                                                                                                            AAL53801.1   1.68   3       7    191    Q-TOF
  Carbohydrate metabolism     BMEI0310    Glycéraldehyde 3-phosphate deshydrogenase                                                                                         AAL51491.1   1.44   3       9    187    Q-TOF
                              BMEI1413    GDP-mannose 4,6-dehydratase                                                                                                       AAL52594.1   0.68   7       16   412    Q-TOF
                              BMEI1779    Fructokinase                                                                                                                      AAL52960.1   1.61   4       13   246    Q-TOF
                              BMEII0358   2-dehydro-3-dehydro-phosphogalactonase aldolase                                                                                   AAL53600.1   1.38   2       10   141    Q-TOF
  Cell wall/envelope          BMEI0727    [d]{.smallcaps}-alanine-[d]{.smallcaps}-alanine ligase A                                                                          AAL51908.1   1.71   6       13   376    Q-TOF
  Central metabolism          BMEI0138    Succinyl coA synthetase beta chain                                                                                                AAL51320.1   1.91   8       18   545    Q-TOF
                              BMEI0161    Succinate dehydrogenase                                                                                                           AAL51343.1   0.16   5       9    310    Q-TOF
                              BMEI0836    Citrate synthase                                                                                                                  AAL52017.1   0.56   2       4    120    Q-TOF
                              BMEI0851    Enolase                                                                                                                           AAL52032.1   1.34   10      20   614    Q-TOF
                              BMEII0248   Phosphoglycerate mutase                                                                                                           AAL53489.1   1.74   4       19   228    Q-TOF
                              BMEII0511   Phosphogluconate dehydratase                                                                                                      AAL53753.1   0.08   2       3    144    Q-TOF
  Lipid metabolism            BMEI0543    Choloylglycine hydrolase                                                                                                          AAL51724.1   0.11   6       13   375    Q-TOF
                              BMEI1112    3-oxo-acyl-carrier protein synthase                                                                                               AAL52293.1   1.65   5       12   327    Q-TOF
                              BMEI1196    EnoylCoA hydratase                                                                                                                AAL52377.1   1.51   2       7    113    Q-TOF
                              BMEI1512    Enoyl-(acyl-carrier protein) reductase                                                                                            AAL52693.1   0.74   7       23   453    Q-TOF
  Nucleotide metabolism       BMEI1643    *N*-carbamoyl-[l]{.smallcaps}-amino acid amidohydrolase                                                                           AAL52824.1   1.62   3       7    210    Q-TOF
  Other metabolism            BMEI0176    Porphobilinogene deaminase                                                                                                        AAL51358.1   0.13   3       10   203    Q-TOF
                              BMEI0219    Malonate semialdehyde dehydrogenase                                                                                               AAL51401.1   0.51   3       7    184    Q-TOF
                              BMEI0712    CBIG protein/precorrin-3B C17-methyltransferase                                                                                   AAL51893.1   0.08   3       5    231    Q-TOF
                              BMEI1588    Carboxynorspermidine dehydrogenase                                                                                                AAL52769.1   0.72   3       8    204    Q-TOF
  Protein synthesis           BMEI0481    LSU Ribosomal Protein L25P                                                                                                        AAL51662.1   0.71   6       21   472    Q-TOF
                              BMEI0742    EF-Tu                                                                                                                             AAL51923.1   1.98   14      37   1130   Q-TOF
                              BMEI1483    50S ribosomal Protein L9                                                                                                          AAL52664.1   0.12   2       9    121    Q-TOF
                              BMEI1915    SSU ribosoma protein S1P                                                                                                          AAL53096.1   1.77   2       3    155    Q-TOF
  Regulation                  BMEI0626    Transriptional regulator GntR familly                                                                                             AAL51807.1   2.64   2       5    110    Q-TOF
                              BMEII0299   IclR family transcriptional regulator                                                                                             AAL53541.1   0.73   2       7    83     Q-TOF
                              BMEII1116   LuxR regulator VjbR                                                                                                               AAL54358.1   0.55   2       9    164    Q-TOF
  Replication/transcription   BMEI0588    DNA repair protein RecN                                                                                                           AAL51769.1   0.21   4       8    344    Q-TOF
                              BMEI0749    DNA-directed RNA polymerase beta chain                                                                                            AAL51930.1   0.30   7       4    458    Q-TOF
                              BMEI1823    DNA gyrase B                                                                                                                      AAL53004.1   0.60   7       8    417    Q-TOF
  Respiration                 BMEI0096    Electron transfer flavoprotein beta subunit                                                                                       AAL51278.1   1.54   6       27   435    Q-TOF
                              BMEI0249    ATP Synthase Alpha Chain                                                                                                          AAL51431.1   0.76   5       9    329    Q-TOF
                              BMEI0487    ATP synthase beta subunit/transription termination factor rho                                                                     AAL51668.1   1.61   4       11   216    Q-TOF
  Stress/chaperone            BMEI0123    Peptidyl-prolyl cis−trans isomerase                                                                                               AAL51278.1   1.52   7       21   426    Q-TOF
                              BMEI0195    ATP-Dependent Clp Protease, ATP-Binding Subunit ClpB                                                                              AAL51377.1   0.74   18      20   1275   Q-TOF
                              BMEI0613    Protease DO                                                                                                                       AAL51794.1   1.66   7       12   465    Q-TOF
                              BMEI2002    DnaK                                                                                                                              AAL53183.1   1.78   15      22   1049   Q-TOF
                              BMEII0401   Thioredoxine                                                                                                                      AAL53643.1   1.71   3       9    224    Q-TOF
                              BMEII1048   GroEL                                                                                                                             AAL54290.1   0.63   21      48   1727   Q-TOF
  Transport/secretion         BMEI1716    Trehalose maltose Binding Protein                                                                                                 AAL52897.1   1.62   5       11   328    Q-TOF
                              BMEI1930    Leucine-, isoleucine-, valine-, threonine-, and alanine-binding protein precursor                                                 AAL53111.1   1.61   2       7    133    Q-TOF
                              BMEII0098   High affiny branched chain amino acid transport ATP-binding protein livF                                                          AAL53339.1   1.38   3       10   166    Q-TOF
                              BMEII0590   Sugar binding protein                                                                                                             AAL53832.1   2.68   11      27   781    Q-TOF
                              BMEII0601   Cystine binding periplasmic protein                                                                                               AAL53843.1   1.38   4       13   303    Q-TOF
                              BMEII0734   Periplasmic oligopeptide Binding protein precursor                                                                                AAL53976.1   1.76   8       16   589    Q-TOF
                              BMEII0923   Spermidine/putrescine-binding protein                                                                                             AAL54165.1   1.52   3       9    193    Q-TOF
  Unassigned                  BMEI1201    Hypothetical cytosolic protein                                                                                                    AAL52382.1   2.64   6       17   477    Q-TOF
                              BMEI1211    General L-amino acid-binding periplasmic protein AAPJ precursor                                                                   AAL52392.1   2.07   2       5    151    Q-TOF
                              BMEI1747    aldehyde dehydrogenase                                                                                                            AAL52928.1   0.66   5       9    360    Q-TOF
                              BMEI1819    Alcohol dehydrogenase deshydrogenase                                                                                              AAL53000.1   1.44   3       7    192    Q-TOF
  Δ*vjbR*, pH 4−7                                                                                                                                                                                                   
  A.A. metabolism             BMEI0101    Cysteine synthase A                                                                                                               AAL51283.1   0.68   2       7    147    Q-TOF
                              BMEI0386    Succinate semialdehyde dehydrogenase                                                                                              AAL51567.1   1.72   5       11   352    Q-TOF
                              BMEI1925    Acetyl-CoA Carboxylase Alpha Chain/Propionyl-CoA Carboxylase Alpha Chain                                                          AAL53106.1   0.75   4       5    244    Q-TOF
  Central metabolism          BMEI0851    Enolase                                                                                                                           AAL52032.1   0.56   5       11   311    Q-TOF
  Nucleotide metabolism       BMEI0522    Carbamoyl Phosphate synthase large subunit                                                                                        AAL51703.1   0.60   12      9    725    Q-TOF
                              BMEI1127    Phosphoribosylformylglycinamidine Synthase                                                                                        AAL52308.1   0.83   7       8    429    Q-TOF
  Protein synthesis           BMEI0837    Glutamyl tRNA synthase                                                                                                            AAL52018.1   1.64   2       3    121    Q-TOF
                              BMEI1047    Tyrosyl tRNA synthase                                                                                                             AAL52228.1   0.68   5       10   332    Q-TOF
  Regulation                  BMEI0417    PdhS                                                                                                                              AAL51598.1   0.70   4       5    232    Q-TOF
                              BMEI0558    Transcriptional regulator ArsR                                                                                                    AAL51739.1   0.68   5       15   389    Q-TOF
  Replication/transcription   BMEI0880    Single strand binding protein                                                                                                     AAL52061.1   2.03   4       22   263    Q-TOF
  Transport/secretion         BMEII0105   Iron regulated outer membrane protein FrpB                                                                                        AAL53346.1   0.80   4       6    244    Q-TOF
  Δ*babR*, pH 7−11 NL                                                                                                                                                                                               
  Cell wall/envelope          BMEI1404    Mannosyltransferase                                                                                                               AAL52585.1   1.38   1119    35   151    Maldi-TOF
  Other metabolism            BMEI0859    Lipoyl synthetase                                                                                                                 AAL52040.1   0.52   14148   46   123    Maldi-TOF
  Δ*vjbR*, pH 7−11 NL                                                                                                                                                                                               
  A.a. metabolism             BMEI1970    *S*-adenosylmethionine synthetase                                                                                                 AAL53151.1   1.7    4       8    268    Q-TOF
  Cell wall/envelope          BMEI0035    [d]{.smallcaps}-alanyl-[d]{.smallcaps}-alanine carboxypeptidase                                                                   AAL51217.1   1.42   25158   75   214    Maldi-TOF
                              BMEI0575    UDP-*N*-acetylmuramoylalanyl-[d]{.smallcaps}-glutamyl-2,6-diaminopimelate-[d]{.smallcaps}-alanyl-[d]{.smallcaps}- alanyl ligase   AAL51756.1   3.26   11141   33   98     Maldi-TOF
                              BMEI1029    Outer membrane protein TolC                                                                                                       AAL52210.1   4.22   16148   33   108    Maldi-TOF
                              BMEI1435    Polysaccharide deacetylase                                                                                                        AAL52616.1   0.37   8115    45   103    Maldi-TOF
                              BMEII0374   Alanine racemase                                                                                                                  AAL53616.1   1.45   17121   50   110    Maldi-TOF
                              BMEII1028   Tetraacyldisaccharide 4′-kinase                                                                                                   AAL54270.1   0.52   16127   62   147    Maldi-TOF
  Protein synthesis           BMEI0741    23S rRNA methyltransferase                                                                                                        AAL51922.1   0.68   9144    55   73     Maldi-TOF
                              BMEI0747    LSU ribosomal protein L10P                                                                                                        AAL51928.1   2.37   614     37   78     Maldi-TOF
                              BMEI0753    SSU ribosomal protein S7P                                                                                                         AAL51934.1   1.93   5112    44   58     Maldi-TOF
                              BMEI1169    SSU ribosomal protein S9P                                                                                                         AAL52350.1   1.93   317     17   42     Maldi-TOF
                              BMEI1267    Dimethyladenosine transferase                                                                                                     AAL52448.1   0.40   1017    51   155    Maldi-TOF
  Regulation                  BMEI0808    Transcriptional Regulator, MerR Family                                                                                            AAL51989.1   0.73   615     34   79     Maldi-TOF
  Replication/transcription   BMEI1035    Atp-dependent rna helicase                                                                                                        AAL52216.1   1.5    4       9    268    Q-TOF
  Transport/secretion         BMEI0469    Purine nucleoside permease                                                                                                        AAL51650.1   0.18   913     29   138    Maldi-TOF
                              BMEII0032   Channel protein VirB8 homologue                                                                                                   AAL53273.1   0.26   912     53   157    Maldi-TOF
                              BMEII0033   Channel protein VirB9 homologue                                                                                                   AAL53274.1   0.49   611     36   100    Maldi-TOF
                              BMEII0593   Glucose ABC transporter ATPase                                                                                                    AAL53835.1   2.92   11116   45   133    Maldi-TOF
                              BMEII0863   Oligopeptide transport ATP-binding protein appD                                                                                   AAL54105.1   1.45   17124   38   183    Maldi-TOF
  Unassigned                  BMEI1193    Cell wall degradation protein                                                                                                     AAL52374.1   0.75   8117    18   69     Maldi-TOF
                              BMEII0002   Ribosomal-protein-serine acetyltransferase                                                                                        AAL53243.1   1.4    817     45   118    Maldi-TOF
                              BMEII0431   Oxidoreductase                                                                                                                    AAL53673.1   2.47   10115   26   109    Maldi-TOF

  B                                                                                                                                                                         
  --------------------- --------------------- ----------- ------------------------------------------------ ------------ ------ ----------------- --- ----- ---------- ---- -------
  Δ*babR*, pH 4−7                                                                                                                                                           
                        AA metabolism         BMEI0516    Aspartate aminotransferase                       AAL51697.1   0.68   QAAIAAINR         2   51    464,2757   2+   Q-TOF
                        Central metabolism    BMEI0791    Isocitrate deshydrogenase                        AAL51972.1   0.68   ASFNYGLKR         2   49    528,2996   2+   Q-TOF
                        Central metabolism    BMEI1436    pyruvate phosphate dikinase                      AAL52617.1   0.47   TPQNITEEAR        1   68    579,815    2+   Q-TOF
                        Stress/chaperone      BMEI1367    Superoxide Dismutase Mn                          AAL52548.1   1.38   LLEGSGLEGK        4   48    501,78     2+   Q-TOF
                        Transport/secretion   BMEII0593   ATP GDP Binding protein ABC transporter          AAL53835.1   1.93   SVFFDSASQTR       2   51    622,8208   2+   Q-TOF
                        Unassigned            BMEI1939    D-3-phosphoglycerate dehydrogenase               AAL53120.1   0.60   GSLQNEPDILAALDR   4   121   806,4188   2+   Q-TOF
  Δ*vjbR*, pH 7−11 NL                                                                                                                                                       
                        Cell wall/envelope    BMEI0223    Membrane-bound lytic murein transglycosylase B   AAL51405.1   2.56   YAQATINADR        3   79    561,8065   2+   Q-TOF

A. Proteins identified in the 2D-DIGE analysis of *babR* and *vjbR* mutant strains. B. Proteins identified by one single peptide in the 2D-DIGE analysis of *babR* and *vjbR* mutant strains. BMEnnnnn: ORF number; F.C.: fold change compared with the wild type strain; \# peptides: numbers of unique peptides identified (for MALDI identification: number of peaks that match to the tryptic peptides vs. number of peaks that do not match to the tryptic peptides); C %: percentage sequence coverage of the protein; Score: identity score; Method: method used for the identification of the protein.

Transcriptomic Analysis of Brucella QS Mutants {#sec3.2}
----------------------------------------------

We chose to combine our 2D-DIGE analysis with a transcriptomic study of both QS mutants. Total RNA samples taken at the proteomic analysis step (from the same cultures) were used to maximize the correlation between these two complementary approaches. RNA samples were pooled, retro-transcribed and labeled before hybridization to a *B. melitensis* DNA microarray (Nimblegen).

The gene expression pattern of the Δ*vjbR* strain was compared to profiles generated from the *B. melitensis* 16 M strain. This analysis led to the identification of 296 coding sequences (CDS) (9.2% of the genome) differentially expressed in the *vjbR* mutant strain (see Supplementary Table 1, [Supporting Information](#si1){ref-type="notes"}). Contrary to what was expected based on previous experiments examining the expression of the *virB* and *fliF* promoters,([@ref19]) a subset of the predicted VjbR regulon is overexpressed in the mutant strain.

The gene expression pattern of the Δ*babR* strain was compared to profiles generated from the parental strain and revealed that BabR regulated the expression of 42 CDS in *B. melitensis* 16 M (1.3% of the genome, see Supplementary Table 1, [Supporting Information](#si1){ref-type="notes"}).

Our analysis reveals that the regulation of a significant fraction of the *B. melitensis* 16 M genome is influenced by a mutation affecting the QS system. This is consistent with the proposition that QS could act as a global regulatory system in this intracellular pathogen. Similar observations have been previously made in *Escherichia coli*([@ref44]) and in the opportunistic pathogen *Pseudomonas aeruginosa*.^[@ref45]−[@ref47]^ However, we suspect that LuxR-type regulators may directly control only for a fraction of the identified target genes since the expression of genes encoding several transcriptional or post-transcriptional regulators is affected by the Δ*vjbR* and/or the Δ*babR* mutations as can be seen Table [2](#tbl2){ref-type="table"}F.

###### Targets Identified in This Study[a](#tbl2-fn1){ref-type="table-fn"}

  --
  --

Summary table of targets genes identified in this study and connections with other published results. Each target is defined by a BMEnnnnn number (corresponding to the ORF number of the gene in *Brucella melitensis* 16 M genome), a functional class and a predicted function. A: Cell wall biogenesis and transport/secretion subclasses. B: Metabolism subclass. C: Translation subclass. D: Respiration process subclass. E: Stress response subclass. F: Regulation subclass. G: Unclassified targets. In the fold change column, colors represent the regulator's effect: red when the regulator exerts a repressive role (fold change \>1.3) and green when the regulator exerts an activation role (fold change \<0.7). Light colors were used for genes with a lower fold change (pink: 1.3 \> fold change \>1.2; olive-green: 0.8 \> fold change \>0.7). Twenty-nine targets of interest were analyzed by qRT-PCR on new biological samples to validate microarray results. These results are listed in the "Ratio mutant/wt qRT-PCR" column. The "VirB Box" column indicates with a "+" genes containing in their promoter sequence the box identified by de Jong([@ref35]) for VjbR regulation. "Operon" column indicates genes which are predicted by BioCyc or KEGG DAS to be part of an operon. Positive results for VjbR ChIP experiments are labeled with a "+" in the "VjbR ChIP validation" column. When biological validations were available (such as Western blots, bile salts resistance test.. .), mutant strain's name tested can been found in the "Biological validation" column. In the last column, genes identified by a "+" have been found by Lamontagne and coworkers([@ref17]) to be implicated in *Brucella abortus* intracellular adaptation. ND: not determined.

Notably, several previously known VjbR-regulated genes were identified in this transcriptomic study, (e.g., *virB* and *omp* genes) thus providing an "a priori" validation for the use of the microarray analysis.

Validation of Transcriptional Profiling Results by qRT-PCR {#sec3.3}
----------------------------------------------------------

To further validate the results collected from the microarray analysis, we performed a reverse transcription experiment followed by quantitative PCR (qRT-PCR) on RNA samples prepared at exponential growth phase (same OD~600nm~ as the transcriptomic experiments but harvested from new cultures). Total RNA was extracted from *B. melitensis* 16 M and isogenic Δ*vjbR* and Δ*babR* mutants. We selected 29 CDS of particular interest (including CDS putatively involved in stress response, virulence and central metabolism) for this analysis. As shown in Table [2](#tbl2){ref-type="table"}, for all the genes tested, the fold changes in transcription detected by qRT-PCR are similar to the fold changes detected by the microarray analysis. A negative control used for each qRT-PCR reaction showed that no genomic DNA contamination occurred in the RNA samples (data not shown).

Selection of the Most Confident *B. melitensis* QS Targets {#sec3.4}
----------------------------------------------------------

We used both proteomic and transcriptomic analyses of *vjbR* and *babR* mutants to define the QS regulon of *B. melitensis* 16 M. In order to select the most confident targets, the results obtained with these two complementary methods were combined with previous data on genes regulated by VjbR and BabR.^[@ref19],[@ref28],[@ref36]^ As the proteomic analysis was performed on three independent samples whereas the transcriptomic one was done on a pool of the corresponding RNA samples, we first based our selection on targets identified by the 2D-DIGE analysis (*n* = 99). We then added to the list CDS identified in the transcriptomic analysis only if they have been confirmed by qRT-PCR (*n* = 29), ChIP (*n* = 8) or a previous biological validation (*n* = 14). Finally, we added CDS predicted to belong to the same transcriptional unit as one of the above selected CDS (*n* = 38). Using this combinatorial analysis, we got a selection of 149 genes whose expression or the amount of gene products formed is affected (directly or indirectly) by VjbR and/or BabR, they are listed in Table [2](#tbl2){ref-type="table"}.

Connections between the Two Brucella QS-Regulators {#sec3.5}
--------------------------------------------------

Analysis of the combined data led to the observation that 27 targets are regulated by both BabR and VjbR (Table [3](#tbl3){ref-type="table"}). The two regulators act in an opposite way on 55% of the genes, including the *virB* genes, and genes encoding chaperones and transporters. These results strongly suggest a crosstalk between the two QS-regulators of *Brucella.* Two recent studies demonstrate that VjbR activates its own expression.^[@ref30],[@ref36]^ One of these studies demonstrated a positive regulatory effects of both QS regulators on their own genes as well as the gene encoding the other regulator.([@ref30]) However, our transcriptomic analysis revealed that VjbR has a 2-fold activating effect on *babR* expression whereas BabR has a 1.5-fold repressing effect on *vjbR* (Table [2](#tbl2){ref-type="table"}). This observation was confirmed by two different qRT-PCR experiments performed on RNA samples harvested from new cultures (Table [2](#tbl2){ref-type="table"} and Table [4](#tbl4){ref-type="table"}).

###### VjbR and BabR Shared Targets: ORFs Identified by the Proteomic and Transcriptomic Analyses and Regulated by Both LuxR Type Regulators

                                     target      identity/similarity/function                                                                            ratio Δ*vjbR*/wt   ratio Δ*babR*/wt
  ---------------------------------- ----------- ------------------------------------------------------------------------------------------------------- ------------------ ------------------
  Co-regulated targets               BMEI0056    LSU Ribosomal Protein L28P                                                                              2.27               1.34
                                     BMEI0195    ATP-Dependent Clp Protease, ATP-Binding Subunit ClpB                                                    1.26               1.57
                                     BMEI0223    Membrane Bound Lytic Murein Transglycolase                                                              2.56               1.38
                                     BMEI0742    Protein Translation Elongation Factor Tu (EF-Tu)                                                        1.81               1.30
                                     BMEI0753    SSU Ribosomal Protein S7P                                                                               1.37               1.26
                                     BMEI0754    Protein Translation Elongation Factor G (EF-G)                                                          1.71               1.28
                                     BMEI0874    ATP-Dependent Clp Protease Proteolytic Subunit                                                          1.66               1.49
                                     BMEI1480    SSU Ribosomal Protein S6P                                                                               2.09               1.35
                                     BMEI1481    SSU Ribosomal Protein S18P                                                                              1.76               1.27
                                     BMEI1747    Aldehyde Dehydrogenase                                                                                  2.37               1.98
                                     BMEI1915    SSU Ribosomal Protein S1P                                                                               1.26               1.46
                                     BMEII0593   Glucose ABC Transporter ATPase                                                                          2.92               1.93
  Differentially regulated targets   BMEI0219    Malonate-Semialdehyde Dehydrogenase (Acylating)/Methylmalonate-Semialdehyde Dehydrogenase (Acylating)   3.27               0.67
                                     BMEI0469    Purine Nucleoside Permease                                                                              0.45               1.35
                                     BMEI0668    Calcium Binding Protein                                                                                 5.77               0.59
                                     BMEI0727    [d]{.smallcaps}-Alanine-[d]{.smallcaps}-Alanine Ligase A                                                0.60               1.28
                                     BMEI0851    Enolase                                                                                                 0.56               1.34
                                     BMEII0025   Attachment Mediating Protein VirB1 Homologue                                                            0.15               1.43
                                     BMEII0026   Attachment Mediating Protein VirB2 Homologue                                                            0.11               1.57
                                     BMEII0027   Channel Protein VirB3 Homologue                                                                         0.15               1.56
                                     BMEII0028   ATPase VirB4 Homologue                                                                                  0.33               1.56
                                     BMEII0029   Attachment Mediating Protein VirB5 Homologue                                                            0.26               1.37
                                     BMEII0030   Channel Protein VirB6 Homologue                                                                         0.61               1.26
                                     BMEII0032   Channel Protein VirB8 Homologue                                                                         0.50               1.55
                                     BMEII0033   Channel Protein VirB9 Homologue                                                                         0.72               1.58
                                     BMEII1047   10 kDa Chaperonin GroES                                                                                 0.49               2.95
                                     BMEII1048   60 kDa Chaperonin GroEL                                                                                 0.35               3.19

###### Validation of Some Targets by qRT-PCR and Analysis of C~12~−HSL Effect[a](#tbl4-fn1){ref-type="table-fn"}

                        *babR*   *vjbR*   *dnaK*   *virB2*   *groEL*   *groES*   BMEI0433   BMEI0668   BMEII0625
  --------------------- -------- -------- -------- --------- --------- --------- ---------- ---------- -----------
  wt + ACN              1.0      1.0      1.0      1.0       1.0       1.0       1.0        1.0        1.0
  wt + C~12~−HSL        2.6      0.5      1.6      0.2       2.0       2.2       2.1        4.5        1.8
  Δ*babR* + ACN         0        1.7      1.9      1.9       3.1       2.7       1.1        0.6        0.8
  Δ*babR* + C~12~−HSL   0        0.3      1.8      0.1       4.0       3.3       0.8        3.5        2.2
  Δ*vjbR* + ACN         0.7      0        0.9      0.1       0.1       0.1       2.9        4.5        3.8
  Δ*vjbR* + C~12~−HSL   1.5      0        1.2      0.1       0.2       0.2       4.4        9.7        4.9

Comparison of fold change ratios for mRNA from wt, Δ*babR* and Δ*vjbR* strains with or without C~12~−HSL. RNA was extracted at an equivalent OD600 for the transcriptomic and the qRT-PCR experiments. ACN: Acetonitrile: C~12~−HSL solvent. C~12~−HSL: dodecanoyl-L-homoserine lactone (added to the culture media at a final concentration of 5 mM). We considered that gene expression is different between wt and mutant strain when the ratio is \>1.3 or \<0.7.

A recent study by Rambow-Larsen and collaborators identified 36 BabR (that they called BlxR) target genes based on a microarray analysis restricted to 289 genes selected for their potential involvement in virulence.([@ref30]) Among these 36 targets, only 8 were common to our analysis (8 genes encoding VirB proteins). Strikingly, whereas these genes appeared to be activated by BabR in the study of Rambow-Larsen, they appeared to be repressed in our analysis. These discrepancies could be in part explained by the differences in the experimental design of these two experiments (growth phase, culture medium, and microarray design).

Impact of C~12~−HSL on Selected QS Targets {#sec3.6}
------------------------------------------

To assess the effect of C~12~−HSL on selected target genes, we performed qRT-PCR on total RNA extracted from *B. melitensis* 16 M and isogenic Δ*vjbR* and Δ*babR* mutants grown with or without C~12~−HSL to an OD~600\ nm~ of 0.7. Results are presented in Table [4](#tbl4){ref-type="table"}; wt strain cultivated without addition of C~12~−HSL was used as a benchmark. Regarding the expression of the genes encoding the two LuxR regulators in the parental strain, *vjbR* expression is repressed when exogenous C~12~−HSL is added whereas *babR* expression is activated. The fact that the C~12~−HSL effect on *vjbR* expression was observed in both the *B. melitensis* 16 M and the *babR* mutant suggests that VjbR regulates its own negative feedback loop. A similar proposal could be also suggested for BabR, but with a positive feedback loop.

Table [4](#tbl4){ref-type="table"} shows that, except for *virB*2 and *vjb*R, C~12~−HSL activates the expression of target genes in *B. melitensis* 16 M. Interestingly, depending on the target gene, the C~12~−HSL activating effect seems to be mostly dependent either on BabR (e.g., BMEI0433), VjbR (*e.g. dnaK*) or both regulators (e.g., BMEI0668 and BMEII0625). Because the effect of C~12~−HSL on some targets (e.g., BMEI0433) is still observed in the Δ*vjbR* strain (but not in the *ΔbabR* strain) and VjbR and BabR are the only predicted proteins possessing a predicted AHL-binding domain in *B. melitensis* 16 M, this result is the first evidence suggesting that BabR can respond to C~12~−HSL. The fact that two regulators react to the same signal molecule is quite unusual. One possibility could be that the two regulators have a different affinity for the C~12~−HSL. For example VjbR may respond to a lower level of AHLs once inside the cell and when a higher AHL concentration is reached, BabR may be activated. This will be an interesting hypothesis to test since we propose that BabR can modulate VjbR activity. Nevertheless, we cannot exclude the possibility that other unidentified AHLs may act preferentially on one or the other LuxR-type regulator.

Global Impact of QS on *Brucella melitensis* 16 M {#sec3.7}
-------------------------------------------------

### Cell Wall/Envelope Biogenesis and Transport/Secretion Proteins {#sec3.7.1}

As shown in Table [2](#tbl2){ref-type="table"}A, VjbR and BabR affect many genes involved in cell envelope biogenesis and membrane transport. These genes constitute the largest class identified in the *B. melitensis* 16 M QS regulon. As expected from previous work in our laboratory,^[@ref19],[@ref28]^ the involvement of VjbR in the regulation of genes encoding components of the type four secretion system (T4SS) and outer membrane proteins (OMP) is observed. The identification of numerous membrane proteins whose genes are regulated by VjbR in this analysis further emphasized the role of VjbR in the control of membrane components. Interestingly, in addition to genes encoding OMPs, several genes predicted to be involved in murein and polysaccharide synthesis and LPS biogenesis are also regulated by VjbR.

Regarding the T4SS, a major component in *Brucella* virulence, we note a clear and inverse regulatory effect between the two LuxR regulators. VjbR activates the transcription of the *vir*B operon (as previously described^[@ref19],[@ref28]^), while BabR had a repressing effect on these genes. This observation was confirmed by two independent qRT-PCR experiments (Tables [2](#tbl2){ref-type="table"} and [4](#tbl4){ref-type="table"}).

Numerous genes predicted to be involved in amino acid, oligopeptide and sugar transport were found to be QS targets in *B. melitensis* 16 M (Table [2](#tbl2){ref-type="table"}A) and many of these genes appear to be regulated by VjbR. The fact that a lot of genes putatively involved in amino acid and sugar transport are part of the QS regulon suggests that a metabolic switch could be initiated by QS.

### Metabolism Pathways {#sec3.7.2}

As can be seen in Table [2](#tbl2){ref-type="table"}B, our analyses of *vjbR* and *babR* mutants revealed that numerous genes and/or proteins involved in metabolic pathways are regulated by QS in the parental 16 M strain. Figure [1](#fig1){ref-type="fig"} presents a schematic view of the main central metabolic pathways in *B. melitensis* 16 M, and the effects of *vjbR* and *babR* mutations on these pathways. Transcriptomic analysis revealed that VjbR exerts a repressive effect on numerous genes encoding enzymes involved in TCA cycle and glycolysis. As for BabR, proteomic analysis showed an activation effect on these two pathways. Interestingly, this same group of targets, constituted by BMEI0851 (enolase), BMEI0836 (citrate synthase), BMEI0791 (isocitrate dehydrogenase), BMEI0161 and BMEI0162 (succinate dehydrogenases) and BMEI0231 (NAD specific glutamate dehydrogenase) was regulated differentially depending upon the LuxR regulator, suggesting that QS could have a global reorganization effect on central metabolic processes. BabR also exerts a repressive effect on fatty acid metabolism genes in the parental strain.

![Diagram representing the main metabolic pathways in the wt strain and the regulation effect of VjbR and BabR. Pentose-P, pentose phosphate pathway; TCA, tricarboxylic acid cycle; G1P, glycerol-1-P; F6P, fructose-6-P; Ga3P, glyceraldehyde-3-P; 3PG, 3-P-glycerate; PYR, pyruvate; OXA, oxaloacetate; ISO, isocitrate; SUC; succinate; GLU, glutamate; Bile salt, glycocholate or taurocholate. Red lines/arrows represent repressed pathways while green lines/arrows represent activated pathways by the regulator. a.a., amino acid.](pr-2010-00068p_0003){#fig1}

Both LuxR regulators also have a strong regulatory effect on BMEI0543 (a gene coding for a choloylglycine hydrolase). VjbR repressed the transcription of *cgh* (transcriptional fold change = 1.58) while BabR strongly activated the production of CGH (proteomic fold change = 0.11). A recent study in *B. abortus* has demonstrated the involvement of *cgh* in successful infection of mice through the oral route.([@ref48]) Interestingly CGH is found in *Brucella* culture supernatants and its secretion seems to be VirB-dependent as demonstrated by the analysis of *B. abortus* wt and *virB* mutant strains.([@ref49])*Brucella* QS regulators could thus be involved not only in the regulation of the genes encoding the VirB machinery but also in the regulation of the genes encoding the effectors it secretes. Consequently, we tested the resistance of QS mutants to bile salts. As shown Figure [2](#fig2){ref-type="fig"}, the Δ*babR* strain was significantly more sensitive to bile salts than the *B. melitensis*16 M. In contrast, the Δ*vjbR* strain displayed an enhanced resistance to bile salts, supplying a biological validation of our proteomic/transcriptomic analysis.

![wt, Δ*vjbR* and Δ*babR* resistance to bile salts. Strains were growth in 2YT with bile salts and CFU were compared with cultures in 2YT (100% of survival). Error bars represent standard deviation from three independent experiments. CFU, colony forming unit.](pr-2010-00068p_0004){#fig2}

Despite the fact that VjbR and BabR regulate in an opposite way the same group of genes encoding central metabolic enzymes, we never observed a growth delay for the *vjbR* and *babR* mutant strains in liquid or solid culture in rich media (see for example Figure [1](#fig1){ref-type="fig"}A). However, using the Biotype 100 system (Biomerieux), we noted some differences in carbon substrate assimilation between the parental strain and the *vjbR* and *babR* mutants (data not shown). So the role of the corresponding LuxR regulators in regulating metabolic pathways is worthy of further investigation.

### Protein Synthesis and Respiration {#sec3.7.3}

Numerous genes coding for ribosomal proteins (LSU and SSU ribosomal proteins) and translation factors (EF-Tu, EF-G) are repressed by VjbR and to a lesser extent by BabR suggesting that these regulators depress protein synthesis (Table [2](#tbl2){ref-type="table"}C). As can be seen in Table [2](#tbl2){ref-type="table"}D, VjbR modulates the expression of genes encoding the terminal oxidases of the respiratory chain (activating the ubiquinol oxidase gene (*cyo*) and repressing the cytochrome C oxidase genes *coxA* (BMEI1465), *coxB* (BMEI1466) *ccoN* (BMEI1565) and *ccoO* (BMEI1564). BabR does not appear to control the expression of these cytochrome genes.

### Stress Responses {#sec3.7.4}

Our study suggests that a fraction of the QS targets in *B. melitensis* 16 M may be involved in stress responses (Table [2](#tbl2){ref-type="table"}E). VjbR targets belonging to this category are essentially involved in protein folding (*groES* and *groEL* are activated by VjbR and repressed by BabR) and thiol-disulfide exchange (BMEI1129 and BMEI2022 encoding respectively a glutaredoxin and a thioredoxin are repressed by VjbR). BabR repressed many genes belonging to this functional group. These include *clpP*, *clpA*, and genes coding for the chaperones GroES, GroEL and DnaK, a chaperone identified as necessary for *B. suis* survival in macrophages.([@ref50]) To further examine the role of QS in stress responses in *B. melitensis* 16 M, we tested the resistance of both Δ*vjbR* and Δ*babR* mutants to several kinds of stresses. The two QS mutants behave as the parental strain during the growth at pH 5, pH 7 (figure [3](#fig3){ref-type="fig"}) and at pH 4, pH 6 and pH 8 (data not shown). In contrast, the *vjbR* mutant seems to be delayed its the adaptation to alkaline pH (pH 9). The response of *Brucella* strains to alkaline stress has not been described, but Appelbe et al. have shown that *dnaK* and *groEL* are induced during alkaline stress in *Enterococcus faecalis*.([@ref51]) While numerous genes encoding stress response proteins involved in adaptation to oxidative stress (*hfq*, *clpA*, *clpB*, *sodC*\...) are regulated trough VjbR and BabR in *B. melitensis* 16 M, neither of the QS mutants displayed a higher sensitivity to H~2~O~2~ than the parent strain (data not shown). Likewise, the *vjbR* and Δ*babR* mutants were also insensitive to cold or heat shock (data not shown).

![*B. melitensis* wt, Δ*vjbR* and Δ*babR* response to acid and alkaline stresses. Strains were growth in 2YT pH 5, 7, or 9 and CFU were compared with cultures in 2YT (100% of survival). Error bars represent standard deviation from three independent experiments. CFU, colony forming unit.](pr-2010-00068p_0005){#fig3}

### Regulation, DNA Replication and Transcription {#sec3.7.5}

In addition to the cross talk between the two QS regulators described above, other regulators are part of the QS regulon (Table [2](#tbl2){ref-type="table"}F): PdhS, a histidine kinase involved in cell cycle control,([@ref52]) and four putative transcriptional regulators of the families ArsR, GntR, IclR and MerR.

VjbR represses the transcription of *hfq,* a RNA chaperone that binds small regulatory RNA (sRNAs) and mRNAs to facilitate translational regulation in response to envelope stress, environmental stress and changes in metabolite concentrations and that was described as being crucial both for stationary phase survival and infection in murine model.([@ref53]) An additional interesting observation resulting from the analysis of the VjbR transcriptomic data is the presence of Bru-RS1 sequences near several VjbR targets. Bru-RS1 are conserved palindromic DNA sequences of 103 bp.([@ref54]) Their function is still unknown, but 30% of the 41 full length Bru-RS1 detected in the *B. melitensis* 16 M genome are located upstream (2/12 Bru-RS1) or downstream (10/12 Bru-RS1) of VjbR targets, and all of these genes are repressed by this regulator. We propose that these Bru-RS, when transcribed, could act as regulatory RNAs in conjunction with the Hfq protein, whose gene is also repressed by VjbR. The involvement of sRNA in QS regulatory systems is widespread^[@ref55],[@ref56]^ and often allows a supplementary level of control on QS targets in response to environmental conditions.^[@ref57],[@ref58]^

In general, genes involved in DNA replication and transcription appeared to be activated by BabR and repressed by VjbR in *B. melitensis* 16 M.

### Identification of Direct VjbR Targets Using Chromatin Immunoprecipitation {#sec3.7.6}

The proteomic and transcriptomic approaches used in the study are complementary, but lead to the identification of both direct and indirect targets. The identification of the DNA binding sites recognized by VjbR and BabR would allow the subsequent identification of the whole direct regulon of *Brucella* QS regulators. Given the involvement of VjbR in *B. melitensis* virulence, we focused on the identification of direct targets of VjbR using a chromatin immunoprecipitation assay (ChIP), a technique allowing the detection of protein−DNA interactions *in vivo*. In order to be able to detect a direct binding between VjbR and a target promoter, we used a strain expressing a constitutive VjbR regulator (unresponsive to AHLs). Specifically, the Δ*vjbR*/pSB502 strain expresses the *vjbR*~*HTH*~*-*FLAG allele coding for the helix turn helix domain of VjbR fused with a C-terminal FLAG tag,([@ref28]) under the control of the *E. coli lac* promoter (P*lac*) in a *vjbR* deficient background. As VjbR is essential for the expression of the *virB* operon, we verified that the Δ*vjbR*/pSB502 strain produces the VirB8 protein, indicating the functionality of the VjbR~HTH~-FLAG regulator (data not shown). The immunoprecipitation experiments were performed in parallel with the Δ*vjbR*/pSB502 (Δ*vjbR*, P*lac*-*vjbR*~*HTH*~*-*FLAG) and the Δ*vjbR* strain harboring the empty plasmid (pBBR1-MCS5) as a negative control. Real-Time PCR was then used to quantify upstream regions of the targets displaying the highest ratios observed by the transcriptomic analysis and we performed RT-PCR to quantify the immunoprecipitated upstream regions.

Figure [4](#fig4){ref-type="fig"} illustrates ChIP analysis showing an enrichment of target genes in the VjbR~HTH~-FLAG immunoprecipitation compared to the control immunoprecipitation (nontagged strain). Given that the DNA was sonicated to obtain fragments with an average size of 500 bp, these results suggest that VjbR is able to bind to the promoter region of *virB* operon, *omp25b* (BMEI1007), *omp36* (BMEI1305), BMEI0668 coding for a putative calcium binding protein, BMEI0030 coding for a hypothetical protein conserved in *P. aeruginosa* (36% of identity, 60% of similarity), and BMEII0590 and BMEII0734 both encoding for components of ABC transporters (specific for sugars and oligopeptides, respectively). Interestingly, three regions of the *virB1-virB2* locus seem to be bound by VjbR. The first one (locus 1 on the top of figure [2](#fig2){ref-type="fig"}) corresponds to the previously defined P*virB* promoter.([@ref59]) The other two correspond to the *virB1-virB2* intergenic region (435 bp). The group of Sieira et al. has demonstrated by primer extension that *virB* transcription starts at a unique site, however the *virB1-virB2* intergenic region also seems to include regulatory site(s).([@ref59]) This proposition has been recently confirmed by the study of de Jong and collaborators([@ref36]) where the authors demonstrated by EMSA that VjbR is able to bind both the *B. abortus* P*virB* and *virB1-virB2* intergenic regions. Our ChIP experiment demonstrated that in *B. melitensis*, VjbR was also able to bind these regions *in vivo*.

![ChIP experiments showing direct binding of VjbR on several promoter regions. (A) Detection of several *virB1-virB2* regions. (B) Detection of BMEII0734, BMEII0590, BMEI0030, BMEI1305, BMEI0668 and BMEI1007 promoter regions. All ChIP were performed with a C-terminal Flag-tagged VjbR-HTH protein expressed from a high copy plasmid (pSB502). The *y*-axis represents the ratio of immunoprecipited product (IP) versus input (IN) (%IP/IN). White columns represent IP from control strain (Δ*vjbR*, empty plasmid), gray columns represent IP from (Δ*vjbR*, pSB502). Error bars represent standard deviation from three independent experiments.](pr-2010-00068p_0006){#fig4}

In an attempt to find the DNA motif recognized by VjbR, we analyzed the upstream regions of genes directly bound by VjbR using the RSAT web resource([@ref60]) and the MEME motif discovery tool,([@ref61]) without success.

Among the 144 genes predicted to be under the control of a consensus *virB* promoter box in *B. abortus*,([@ref36]) we found only 10 of their *B. melitensis* homologues in our screens (Table [2](#tbl2){ref-type="table"}). However, the consensus *virB* promoter VjbR box defined in the study of de Jong([@ref36]) was found in only 3 promoter sequences of the 8 VjbR targets found in our ChIP analysis (BMEI1007, BMEII0025 and BMEII0026). This observation suggests that the VjbR binding site is not well-conserved or is not present in all promoters that are direct targets of VjbR.

Conclusions {#sec4}
===========

Our study is the first report of the impact of QS at the genome scale in an intracellular pathogen. *Brucella* QS was initially discovered through its impact on virulence both in cellular and mouse models,([@ref19]) and the present study confirms that QS regulates numerous genes previously identified as being essential for the full virulence of *Brucella* (Supplementary Table 2, [Supporting Information](#si1){ref-type="notes"}). Nevertheless, the main conclusion of this paper is that QS should not be considered anymore only as a virulence regulatory system, but should also be viewed as a major global coordinator of crucial cellular and metabolic processes related to the adaptation of *Brucella* to its intracellular niche.

Indeed, the proteomic and transcriptomic analyses of the *B. melitensis* QS mutants showed that genes whose products are predicted to perform the following function are regulated by QS: (i) response to oxidative stress (*sodC*, *hfq*\...), (ii) general stress response and protein folding (*groES*, *groEL*\...), (iii) respiration under aerobic conditions (*coxA, coxB, coxC*), (iv) response to varied nutrients availability (sugar and amino acid transporters\...), (v) enzymes of the glycolytic and TCA pathway and (vi) numerous ribosomal proteins. These observations are in agreement with previous claims that *Brucella* strains meet nutritionally poor and microaerobic environments during their infectious cycle^[@ref50],[@ref62]^ and that they engage an adaptive response by quantitative reduction of cellular processes participating in energy, protein, and nucleic acid metabolism.([@ref63])

We propose that VjbR is required early in host cell infection not only to activate the genes encoding the T4SS (necessary to reach the permissive replicative-compartment)([@ref35]) but also for the early adaptation of *B. melitensis* 16 M to the stressful conditions encountered in the vacuole and in the slowdown of this strain's basic metabolism. This would prevent multiplication until the replicative compartment is reached. This proposal is well supported by the recent kinetic analysis of the *B. abortus* proteome during macrophage infection.([@ref17]) After an initial shut down of the intracellular *Brucellae*'s basic cellular processes in the early steps of macrophage infection, a majority of these proteins return to their initial level later during the infection. We propose that BabR could be a player in this latter step since it acts in an opposite way compared to VjbR on several key QS targets including the genes encoding the VirB proteins, GroESL and key central metabolic enzymes.

Particularly striking also is the parallelism that can be drawn between the targets identified as part of the QS regulon in this study and the direct or indirect targets of another major regulator of *Brucella* virulence: the two component system (TCS) BvrS/BvrR. The results presented here, along with those from a previous study([@ref28]) strongly support the involvement of VjbR in the control of envelope properties in *Brucella* strains, and this appears also to be the case for BvrS/BvrR.^[@ref64]−[@ref66]^ More importantly, a recent proteomic analysis of outer membrane fragments released by *B. abortus bvrR*/*bvrS* mutants([@ref67]) pointed out an important increase of periplasmic proteins, ABC transporters and chaperones in these mutants compared to the parent strain. The expression of genes encoding products belonging to these same functional categories are also clearly increased in our v*jbR* mutant (see Table [2](#tbl2){ref-type="table"}A, E). In both the *bvrS/R* mutants and in the *vjbR* mutant, these kinds of changes seem to mimic nutrient starvation. Consequently, BvrS/BvrR was suggested to be directly or indirectly involved in adjusting the metabolism of *Brucella*([@ref67]) and, considering the impact of the QS system on central metabolism (see Table [2](#tbl2){ref-type="table"}B), a similar proposition can be clearly put forth for this latter system. However, neither the analysis of Lamontagne([@ref67]) nor our analyses have demonstrated a link between the BvrS/BvrR system and VjbR. Nevertheless, these analyses have been performed under very dissimilar conditions and we cannot exclude the possibility that these two regulatory pathways could be connected (directly or indirectly through other global starvation sensing mechanisms like the stringent response([@ref68]) and/or the PTS system([@ref18])). Altogether, these systems should contribute to the adaptation of the metabolic network during the nutrient shift faced by *Brucella* all along its intracellular trafficking.

In summary, our results demonstrate that *B. melitensis* 16 M possesses a nonclassical QS regulatory system since: (i) despite the lack of a classical AHL-synthase in this pathogen, QS regulates a large fraction of its genome under the conditions tested, (ii) BabR can behave as a modulator of VjbR activity, (iii) C~12~−HSL have an effect both on BabR and VjbR, and (iv) QS is involved in the intracellular survival of *B. melitensis* through VjbR.

The use of a QS system in the individual vacuole surrounding the *Brucellae* in the host cell represents a good example of "efficiency sensing", in agreement with the definition of Hense and co-workers,([@ref25]) since the diffusion of AHLs in these compartments should be delayed compared to the environments encountered by these bacteria before their entry into host cells. This proposal and the biosynthetic pathway responsible of the production of low amounts of C~12~−HSL([@ref32]) should be further investigated to get further insights on QS in *Brucella* strains.

Abbrevations: {#sec4.1}
-------------

3PG, 3-P-glycerate; AA, amino acid; AcoA, acetyl coenzyme A; AHL, acyl-homoserine lactone; BCV, *Brucella* containing vacuole; CDS, coding sequence; CFU, colony forming unit; ChIP, chromatin immunoprecipitation; DNA, DNA; EPS, exopolysaccharide; ER, endoplasmic reticulum; F6P, fructose-6-P; FC, fold change; Ga3P, glyceraldehyde-3-P; G1P, glycerol-1-P; GLU, glutamate; Gnt, gentamycin; HTH, helix-turn-helix; ISO, isocitrate; LPS, lipopolysaccharide; MacP, malonyl acyl carrier protein; McoA, malonyl coenzyme A; Nal, nalidixic acid; OMP, outer membrane protein; OXA, oxaloacetate; Pentose-P, pentose phosphate pathway; PYR, pyruvate; QS, Quorum Sensing; RNA, ribonucleic acid; SUC, succinate; T4SS, type four secretion system; TCS, two component system; TCA, tricarboxylic acid cycle; wt, wild type.
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